T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Alnylam Pharmaceuticals
ALNY
$30.2B
| $949M | 0.11% |
3,451,833
-36,170
| -1% | -$9.42M |
|
177
Entegris
ENTG
$24.8B
| $942M | 0.11% |
8,368,149
-1,128,432
| -12% | -$134M |
|
178
Fortinet
FTNT
$120B
| $937M | 0.11% |
12,083,499
-16,906,341
| -58% | -$1.15B |
|
179
Insmed
INSM
$28.3B
| $918M | 0.11% |
12,580,981
+417,613
| +3% | +$30.8M |
|
180
Range Resources
RRC
$9.31B
| $916M | 0.11% |
29,763,849
+396,005
| +1% | +$12.3M |
|
|
181
Applied Materials
AMAT
$444B
| $904M | 0.1% |
4,472,666
-6,505,974
| -59% | -$1.33B |
|
182
MongoDB
MDB
$36.8B
| $888M | 0.1% |
3,285,036
-153,395
| -4% | -$39.8M |
|
183
KE Holdings
BEKE
$18.8B
| $882M | 0.1% |
44,274,671
+1,148,086
| +3% | +$16.9M |
|
184
Equitable Holdings
EQH
$14.2B
| $872M | 0.1% |
20,742,765
-332,976
| -2% | -$13.7M |
|
185
Sea Limited
SE
$76.5B
| $863M | 0.1% |
9,153,586
-541,319
| -6% | -$40.8M |
|
186
Travelers Companies
TRV
$77.5B
| $862M | 0.1% |
3,682,448
-331,025
| -8% | -$73M |
|
187
Parker-Hannifin
PH
$133B
| $861M | 0.1% |
1,363,208
+507,782
| +59% | +$288M |
|
188
AvalonBay Communities
AVB
$26.5B
| $859M | 0.1% |
3,815,485
-328,910
| -8% | -$71M |
|
189
SiteOne Landscape Supply
SITE
$4.22B
| $858M | 0.1% |
5,686,852
+870,620
| +18% | +$119M |
|
190
PG&E
PCG
$38.9B
| $857M | 0.1% |
43,331,285
+5,617,938
| +15% | +$105M |
|
191
Northrop Grumman
NOC
$81.8B
| $834M | 0.1% |
1,579,786
+602,756
| +62% | +$295M |
|
192
Revvity
RVTY
$13.1B
| $828M | 0.1% |
6,479,776
+1,156,806
| +22% | +$136M |
|
193
Vertex Pharmaceuticals
VRTX
$133B
| $822M | 0.09% |
1,768,010
-443,664
| -20% | -$213M |
|
194
Exelon
EXC
$47B
| $816M | 0.09% |
20,134,182
+17,906,896
| +804% | +$673M |
|
195
Western Digital
WDC
$168B
| $816M | 0.09% |
15,799,180
-4,024,868
| -20% | -$203M |
|
196
Toro Company
TTC
$9.3B
| $814M | 0.09% |
9,385,021
+503,790
| +6% | +$45.3M |
|
197
Welltower
WELL
$169B
| $813M | 0.09% |
6,351,430
-525,524
| -8% | -$61.3M |
|
198
Datadog
DDOG
$88.9B
| $812M | 0.09% |
7,060,023
+2,177,244
| +45% | +$254M |
|
199
Cisco
CSCO
$455B
| $810M | 0.09% |
15,217,698
+2,109,479
| +16% | +$103M |
|
200
Zoetis
ZTS
$30.5B
| $806M | 0.09% |
4,126,021
-667,904
| -14% | -$123M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.